| |||||
| |||||
Hello Nature readers, | |||||
| |||||
Many foods contain the chemical tryptophan, which, once broken down by gut microorganisms, might improve the results of chemotherapy against pancreatic cancer. (Karl Gaff/Science Photo Library) | |||||
Metabolite boosts chemo in pancreatic cancerA chemical produced through the breakdown of the amino acid tryptophan by bacteria in the gut — indole-3-acetic acid (3-IAA) — could make chemotherapy for pancreatic cancer more effective. People with pancreatic cancer who responded to chemotherapy had higher levels of 3-IAA than people who did not respond to treatment, researchers found. Chemotherapy was also more effective in mice that had their levels of 3-IAA artificially boosted through faecal microbiota transplantation, dietary manipulation or oral 3-IAA administration. People can easily increase the amount of tryptophan in their diet — many foods, including dairy products, chicken, egg whites, soya beans and peanuts, contain it. However, treating people directly with 3-IAA supplements would be ideal for future clinical trials because differences in the gut microbiome affect how well people metabolize tryptophan into 3-IAA. Reference: Nature paper (22 February) | |||||
Antibiotics dampen immunotherapy benefitPeople with cancer were at a higher risk of death if they had taken antibiotics up to one year before being treated with an immunotherapy called immune checkpoint inhibitors, found a study. Fluoroquinolones were the class of antibiotic associated with the worst outcomes. The population-based study of more than 2,700 people is "particularly provocative" in suggesting that antibiotics might affect treatment even before the clinical diagnosis of cancer, two physicians write in an accompanying editorial. Reference: Journal of Clinical Oncology paper (24 February) | |||||
From the Nature Portfolio Cancer Community
| |||||
ACCESS NATURE AND 54 OTHER NATURE JOURNALS Nature+ gives you immediate online access to Nature and 54 other journals. Nature+ is a flexible monthly subscription and is currently available only to personal users in the United States and in the United Kingdom. | |||||
| |||||
Opportunistic removal of fallopian tubesWomen who are not planning to get pregnant and are undergoing pelvic surgery anyway might choose to have their fallopian tubes removed to reduce the risk of ovarian cancer. The procedure — called a salpingectomy — is relatively simple and safe, and does not trigger menopause because the fallopian tubes do not make hormones. Ovarian cancer mostly affects postmenopausal women and is difficult to detect early; fewer than half of women diagnosed with it live for more than five years. STAT | 5 min read | |||||
In the news
| |||||
| |||||
More evidence is emerging that the mind can influence the progression of physical disease. (Illustration by Dalbert B. Vilarino) | |||||
The role of the mind in physical illnessIn a yet-to-be-published study, mice that had heart attacks were less likely to end up with cardiac scar tissue if researchers had stimulated a region of the brain involved in positive emotion. The reward centre of the brain might be triggering a protective immune response, the researchers surmised. "In the beginning we were sure that it was too good to be true," says neuroimmunologist Hedva Haykin. The study is part of a growing field that is investigating how mental states affect how ill we get and how quickly we recover. There seem to be multiple lines of communication between the nervous system and the immune system, and cracking this secret could help treat a range of diseases, even cancer, says neuroimmunologist Asya Rolls. Nature | 13 min read | |||||
The wave of fraud in medical researchOut of 750 scientific papers flagged by Ben Mol and his colleagues as containing potential errors or fraud, only 80 have been retracted. Mol, an obstetrician and gynaecologist, is one of several specialists who are concerned by the volume of dodgy papers being published. Almost 19,000 biomedical-science papers have been retracted, according to a database maintained by scientific-integrity blog Retraction Watch. And the problem is getting worse: there were twice as many retractions in 2022 as in 2018. Many of these papers are coming from prolific fraudsters and 'paper mills', which churn out nonsense research. The Economist | 19 min read (paywall) | |||||
Quote of the week"The major advantage of natural killer cells is they've never killed anybody, unlike CAR-T cells."Pharmaceutical companies are developing immunotherapies using natural killer immune cells instead of modified T cells because they are safer, says immunologist Lewis Lanier. (Nature Biotechnology | 9 min read) | |||||
| |||||
| |||||
| |||||
| |||||
You received this newsletter because you subscribed with the email address: [email protected] Please add [email protected] to your address book. Enjoying this newsletter? You can use this form to recommend it to a friend or colleague — thank you! Had enough? Unsubscribe from Nature Briefing: Cancer. Fancy a bit of a read? View our privacy policy. Forwarded by a friend? Get the Briefing straight to your inbox: subscribe for free. Get more from Nature: Register for free on nature.com to sign up for other newsletters specific to your field and email alerts from Nature Research journals. Nature | The Springer Nature Campus, 4 Crinan Street, London, N1 9XW, United Kingdom Nature Research, part of Springer Nature. |